James Anthony Martin
Known title: Chief Financial OfficerCIK: 0002105348
Associated companies
Transaction History
| LMRI | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 | View on chart |
| LMRI | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 | View on chart |
| LMRI | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 | View on chart |
| LMRI | ▲ Buy | Grant | 27,027 | $0 | 12/12/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Lumexa Imaging (LMRI) Valuation Analysis Published
A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.
Lumexa Imaging (LMRI) Valuation Analysis Published. A recent analysis suggests Lumexa Imaging Holdings may be trading at a discount to its estimated fair value, citing the company's imaging growth story. The stock is currently trading below the average analyst target price of $17.57. This valuation perspective provides context for investors assessing the company's current market position relative to its long-term potential.